SuperworthSchrodinger market cap SDGR
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Oct 23, 2026
- $1.8B
- Highest close in our data
- $7.7B
- Feb 2021
Schrodinger is worth $1.8B at the close on Oct 23, 2026, at $23.80 a share.
That is up 7% over the last year and down 54% over five years.
Its highest close in our data was $7.7B in Feb 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.8B | $818M | $2.3B | +32% |
| 2025 | $1.3B | $1.2B | $1.9B | −6% |
| 2024 | $1.4B | $1.3B | $2.3B | −44% |
| 2023 | $2.6B | $1.3B | $3.8B | +94% |
| 2022 | $1.3B | $1.2B | $2.5B | −46% |
| 2021 | $2.5B | $2.5B | $7.7B | −55% |
| 2020 | $5.5B | $3.1B | $5.9B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Schrodinger's size, closest first, today.
| Company | Market cap |
|---|---|
| SDGRSchrodinger | $1.8B |
| ANIPANI Pharmaceuticals | $1.7B |
| PAHCPhibro Animal Health | $1.6B |
| HRMYHarmony Biosciences | $2.1B |
| ANABAnaptysbio | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| PBHPrestige Consumer Healthcare | $2.3B |
| OMEROmeros | $1.2B |
| NRIXNurix Therapeutics | $2.8B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OGNOrganon | $3.6B |
| Peer median | $1.6B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Schrodinger
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.